The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart-Jones, G. B. E.
Right arrow Articles by Jones, E. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart-Jones, G. B. E.
Right arrow Articles by Jones, E. Y.
The Journal of Immunology, 2005, 175: 2459-2468.
Copyright © 2005 by The American Association of Immunologists

Structures of Three HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Nonprogression1,2

Guillaume B. E. Stewart-Jones3,*, Geraldine Gillespie3,{dagger}, Ian M. Overton{ddagger}, Rupert Kaul§, Philippe Roche*, Andrew J. McMichael{dagger}, Sarah Rowland-Jones{dagger} and E. Yvonne Jones4,*

* Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; {dagger} Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; {ddagger} Biological Chemistry and Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, United Kingdom; and § Clinical Sciences Division, University of Toronto, Toronto, Canada

Long-term nonprogression during acute HIV infection has been strongly associated with HLA-B*5701 or HLA-B*5703. In this study, we present the high resolution crystal structures of HLA-B*5703 complexes with three HIV-1 epitopes: ISPRTLNAW (ISP), KAFSPEVIPMF (KAF-11), and KAFSPEVI (KAF-8). These reveal peptide anchoring at position 2 and their C termini. The different peptide lengths and primary sequences are accommodated by variation in the specific contacts made to the HLA-B*5703, flexibility in water structure, and conformational adjustment of side chains within the peptide-binding groove. The peptides adopt markedly different conformations, and trap variable numbers of water molecules, near a cluster of tyrosine side chains located in the central region of the peptide-binding groove. The KAF-11 epitope completely encompasses the shorter KAF-8 epitope but the peptides are presented in different conformations; the KAF-11 peptide arches out of the peptide-binding groove, exposing a significant main chain surface area. Bioinformatic analysis of the MHC side chains observed to contribute to the peptide anchor specificity, and other specific peptide contacts, reveals HLA alleles associated with long-term nonprogression and a number of related HLA alleles that may share overlapping peptide repertoires with HLA-B*5703 and thus may display a similar capacity for efficient immune control of HIV-1 infection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Tang, W. Shao, Y. J. Yoo, I. Brill, J. Mulenga, S. Allen, E. Hunter, and R. A. Kaslow
Human Leukocyte Antigen Class I Genotypes in Relation to Heterosexual HIV Type 1 Transmission within Discordant Couples
J. Immunol., August 15, 2008; 181(4): 2626 - 2635.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. O. Peters, M. G. Mendoza, R. E. Capina, M. Luo, X. Mao, M. Gubbins, N. J. D. Nagelkerke, I. MacArthur, B. B. Sheardown, J. Kimani, et al.
An Integrative Bioinformatic Approach for Studying Escape Mutations in Human Immunodeficiency Virus Type 1 gag in the Pumwani Sex Worker Cohort
J. Virol., February 15, 2008; 82(4): 1980 - 1992.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. G. Yu, M. Lichterfeld, S. Chetty, K. L. Williams, S. K. Mui, T. Miura, N. Frahm, M. E. Feeney, Y. Tang, F. Pereyra, et al.
Mutually Exclusive T-Cell Receptor Induction and Differential Susceptibility to Human Immunodeficiency Virus Type 1 Mutational Escape Associated with a Two-Amino-Acid Difference between HLA Class I Subtypes
J. Virol., February 15, 2007; 81(4): 1619 - 1631.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Thananchai, G. Gillespie, M. P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D. W. McVicar, K. Maenaka, P. Parham, et al.
Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B
J. Immunol., January 1, 2007; 178(1): 33 - 37.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Miles, N. A. Borg, R. M. Brennan, F. E. Tynan, L. Kjer-Nielsen, S. L. Silins, M. J. Bell, J. M. Burrows, J. McCluskey, J. Rossjohn, et al.
TCR{alpha} Genes Direct MHC Restriction in the Potent Human T Cell Response to a Class I-Bound Viral Epitope
J. Immunol., November 15, 2006; 177(10): 6804 - 6814.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. M. A. Gillespie, G. Stewart-Jones, J. Rengasamy, T. Beattie, Job. J. Bwayo, F. A. Plummer, R. Kaul, A. J. McMichael, P. Easterbrook, T. Dong, et al.
Strong TCR Conservation and Altered T Cell Cross-Reactivity Characterize a B*57-Restricted Immune Response in HIV-1 Infection
J. Immunol., September 15, 2006; 177(6): 3893 - 3902.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Pastori, B. Weiser, C. Barassi, C. Uberti-Foppa, S. Ghezzi, R. Longhi, G. Calori, H. Burger, K. Kemal, G. Poli, et al.
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression
Blood, June 15, 2006; 107(12): 4825 - 4833.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Lazaryan, E. Lobashevsky, J. Mulenga, E. Karita, S. Allen, J. Tang, and R. A. Kaslow
Human Leukocyte Antigen B58 Supertype and Human Immunodeficiency Virus Type 1 Infection in Native Africans.
J. Virol., June 1, 2006; 80(12): 6056 - 6060.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.